Halozyme’s Enhanze™ Technology Gains Much-Needed Boost with Pfizer Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 1 (Table of Contents)
Published: 17 Jan-2013
DOI: 10.3833/pdr.v2013.i1.1872 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Halozyme Therapeutics has partnered with Pfizer to develop and commercialise products combining its Enhanze™ drug delivery platform with Pfizer biologics directed at up to 6 targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS